Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avy Violari

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
The Pediatric Infectious Disease Journal|February 27, 2015
Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients: week 48 results of the ARIEL trialAvy Violari, Rosa Bologna, Nagalingeswaran Kumarasamy, et al.
Journal of the International AIDS Society|June 14, 2014
Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?Steve Innes, Erica Lazarus, Kennedy Otwombe, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
BMC Medicine|July 19, 2014
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of lifeVivek Naranbhai, Soyeon Kim, Helen Fletcher, et al.
Vaccine|July 10, 2017
Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditionsSabelle Jallow, Shabir A Madhi, Richard Madimabe, et al.
AIDS Research and Human Retroviruses|May 19, 2006
Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progressionIsaac Choge, Tonie Cilliers, Polly Walker, et al.
BMC Research Notes|October 28, 2011
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) StudyClotilde Hainline, Reghana Taliep, Gill Sorour, et al.
AIDS Research and Human Retroviruses|October 10, 2018
Naive B Cell Output in HIV-Infected and HIV-Uninfected ChildrenHelen Payne, Gabriel Chain, Stuart Adams, et al.
Plos One|July 2, 2019
A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countriesMark F Cotton, Helena Rabie, Elisa Nemes, et al.
Frontiers in Immunology|October 6, 2017
Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy TrialJoanna Lewis, Helen Payne, A Sarah Walker, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
The Pediatric Infectious Disease Journal|February 27, 2015
Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients: week 48 results of the ARIEL trialAvy Violari, Rosa Bologna, Nagalingeswaran Kumarasamy, et al.
Journal of the International AIDS Society|June 14, 2014
Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?Steve Innes, Erica Lazarus, Kennedy Otwombe, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
BMC Medicine|July 19, 2014
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of lifeVivek Naranbhai, Soyeon Kim, Helen Fletcher, et al.
Vaccine|July 10, 2017
Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditionsSabelle Jallow, Shabir A Madhi, Richard Madimabe, et al.
AIDS Research and Human Retroviruses|May 19, 2006
Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progressionIsaac Choge, Tonie Cilliers, Polly Walker, et al.
BMC Research Notes|October 28, 2011
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) StudyClotilde Hainline, Reghana Taliep, Gill Sorour, et al.
AIDS Research and Human Retroviruses|October 10, 2018
Naive B Cell Output in HIV-Infected and HIV-Uninfected ChildrenHelen Payne, Gabriel Chain, Stuart Adams, et al.
Plos One|July 2, 2019
A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countriesMark F Cotton, Helena Rabie, Elisa Nemes, et al.
Frontiers in Immunology|October 6, 2017
Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy TrialJoanna Lewis, Helen Payne, A Sarah Walker, et al.
Pageof 15